Carbon tetrachloride-induced acute liver toxicity: selecting dosage and biomarkers for evaluating hepatoprotective drugs in ICR outbred mice

by Luangmonkong T.
Published 2023

Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice

by Luangmonkong T.
Published 2023

Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges

by Luangmonkong T.
Published 2023

Prevalence of anti-hypertensive drug prescription in Thailand, a cross sectional study using National Health Security Office database

by Luangmonkong T.
Published 2023

Modified culture protocol for testing anti-fibrotic drugs using precision-cut liver slices

by Theerut Luangmonkong, Peter Olinga
Published 2020

Precision-cut liver slices: A tool for studying multicellular diseases

by Theerut Luangmonkong, ธีรัตถ์ เหลืองมั่นคง
Published 2020

Therapeutic targets for the treatment of cardiac fibrosis and cancer: Focusing on tgf-β Signaling

by Warisara Parichatikanond, Theerut Luangmonkong, Supachoke Mangmool, Hitoshi Kurose
Published 2020

Prevalence of anti-hypertensive drug prescription in Thailand, a cross sectional study using National Health Security Office database

by Theerut Luangmonkong, Jiratchaya Wongsaardsakul, Rujipas Laobutree, Sarawut Jindarat, Nattapon Jaisupa
Published 2022

Host microbiota dictates the proinflammatory impact of LPS in the murine liver

by Su Suriguga, Theerut Luangmonkong, Henricus A.M. Mutsaers, Geny M.M. Groothuis, Peter Olinga
Published 2020

Targeting oxidative stress for the treatment of liver fibrosis

by Theerut Luangmonkong, Su Suriguga, Henricus A.M. Mutsaers, Geny M.M. Groothuis, Peter Olinga, Miriam Boersema
Published 2019

A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices

by Grietje H. Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus A.M. Mutsaers, Frank J. Dekker, Peter Olinga
Published 2020

Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure

by Su Suriguga, Mei Li, Theerut Luangmonkong, Miriam Boersema, Koert P. de Jong, Dorenda Oosterhuis, A. R. Gorter, Leonie Beljaars, Peter Olinga
Published 2022

In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β

by Theerut Luangmonkong, Su Suriguga, Adhyatmika Adhyatmika, Amirah Adlia, Dorenda Oosterhuis, Chuthamanee Suthisisang, Koert P. de Jong, Henricus A.M. Mutsaers, Peter Olinga
Published 2019

Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs

by Raditya Iswandana, Bao Tung Pham, Su Suriguga, Theerut Luangmonkong, Louise A. Van Wijk, Yvette J.M. Jansen, Dorenda Oosterhuis, Henricus Antonius Maria Mutsaers, Peter Olinga
Published 2020

Osteoprotegerin is more than a possible serum marker in liver fibrosis: A study into its function in human and murine liver

by Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S.S. Putri, Habibie Habibie, Carian E. Boorsma, Catharina Reker‐smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A. Mangnus, Eduard Post, Klaas Poelstra, Kim Ravnskjaer, Peter Olinga, Barbro N. Melgert
Published 2020